Brief: Imricor Medical Systems Expects 2H To Be Particularly Strong In Consumable Device Revenue
31/08/2022 01:01
Aug 31 (Reuters) - Imricor Medical Systems Inc IMR.AX :
* EXPECT 2H TO BE PARTICULARLY STRONG IN CONSUMABLE DEVICE
REVENUE
Source text for Eikon: ID:nASX8c4kRC
Further company coverage: IMR.AX
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion